Actionable insights straight to your inbox

Equities logo

FDA Comments Point to Biogen Getting Favorable Advisory Committee Vote on Alzheimer’s Drug Candidate

FDA staff said Wednesday that Biogen has shown “exceptionally persuasive” evidence that its experimental Alzheimer’s disease drug is effective, ahead of Friday's Advisory Committee meeting.